Skip to main content
SPRY logo
SPRY
(NASDAQ)
ARS Pharmaceuticals, Inc.
$8.02-- (--)
Loading... - Market loading

ARS Pharmaceuticals (SPRY) Stock Price & Financial Analysis

ARS Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.38 - $10.87
52-Week High$18.90
52-Week Low$6.66
Open$10.41
Volume1.92M
Average Volume (3M)1.70M
Market Cap1.05B
Shares Outstanding99.30M
Price to Sales (P/S)10.57
Price to Book (P/B)17.07
EV/EBITDA-5.91
Revenue (TTM)98.99M
Net Income (TTM)-197.98M
Free Cash Flow (TTM)-175.32M
EPS (TTM)$-2.00
Profit Margin-200.00%
Operating Margin-204.49%
Return on Equity (ROE)-322.92%
Debt to Equity1.57
50-Day MA$8.69
200-Day MA$9.38
52-Week Change-37.19%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ARS Pharmaceuticals

What is the current stock price for SPRY?

As of the latest trading session, SPRY stock trades at $10.54. The 52-week range is $6.66–$18.90, with a day range of $10.38–$10.87.

What is the P/E ratio for SPRY?

The P/E ratio (Price-to-Earnings) for SPRY is shown in the Key Statistics section. This valuation metric helps compare ARS Pharmaceuticals, Inc. to industry peers.

Does SPRY pay dividends?

ARS Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SPRY?

Based on 4 analysts, the consensus for SPRY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SPRY?

ARS Pharmaceuticals's market capitalization is $1.05B, classifying it as a small-cap company. ARS Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.